I. In 1999, pharmaceutical giant Bristol-Myers Squibb struck a hell of a deal. They reached an agreement with a Japanese pharmaceutical company, Otsuka, to market one of their products in the United States. Under the terms of the agreement, Bristol-Myers would help lead the clinical trials to get the new medication approved by the U.S. […]

Read More The NBOME, Part I: On COMLEX-USA and off-label marketing